TUMOR BURDEN ASSESSMENT AND ITS IMPLICATION FOR A PROGNOSTIC MODEL IN ADVANCED DIFFUSE LARGE-CELL LYMPHOMA

被引:182
作者
JAGANNATH, S
VELASQUEZ, WS
TUCKER, SL
FULLER, LM
MCLAUGHLIN, PW
MANNING, JT
NORTH, LB
CABANILLAS, FC
机构
[1] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, DEPT HEMATOL, 6723 BERTNER AVE, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, DEPT RADIOTHERAPY, HOUSTON, TX 77030 USA
[3] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, DEPT BIOMATH, HOUSTON, TX 77030 USA
[4] UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, DEPT DIAGNOST RADIOL, HOUSTON, TX 77030 USA
关键词
D O I
10.1200/JCO.1986.4.6.859
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:859 / 865
页数:7
相关论文
共 34 条
[11]  
FERRARIS AM, 1979, BLOOD, V54, P928
[12]   PROGNOSTIC FACTORS FOR ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA FOLLOWING TREATMENT WITH COMBINATION CHEMOTHERAPY [J].
FISHER, RI ;
DEVITA, VT ;
JOHNSON, BL ;
SIMON, R ;
YOUNG, RC .
AMERICAN JOURNAL OF MEDICINE, 1977, 63 (02) :177-182
[13]   DIFFUSE AGGRESSIVE LYMPHOMAS - INCREASED SURVIVAL AFTER ALTERNATING FLEXIBLE SEQUENCES OF PROMACE AND MOPP CHEMOTHERAPY [J].
FISHER, RI ;
DEVITA, VT ;
HUBBARD, SM ;
LONGO, DL ;
WESLEY, R ;
CHABNER, BA ;
YOUNG, RC .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (03) :304-309
[14]  
GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
[15]  
GOSPODAROWICZ MC, 1984, P AN M AM SOC CLIN, V3, P236
[16]   STAGE-IV DIFFUSE LARGE-CELL LYMPHOMA - A LONG-TERM ANALYSIS [J].
JAGANNATH, S ;
VELASQUEZ, WS ;
TUCKER, SL ;
MANNING, JT ;
MCLAUGHLIN, P ;
FULLER, LM .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) :39-47
[17]  
JONES SE, 1973, CANCER-AM CANCER SOC, V31, P806, DOI 10.1002/1097-0142(197304)31:4<806::AID-CNCR2820310408>3.0.CO
[18]  
2-1
[19]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[20]   MACOP-B CHEMOTHERAPY FOR THE TREATMENT OF DIFFUSE LARGE-CELL LYMPHOMA [J].
KLIMO, P ;
CONNORS, JM .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (05) :596-602